课题基金 / 基金详情

Mechanisms of Optic Nerve Stroke Neuroprotection

Mechanisms of Optic Nerve Stroke Neuroprotection
视神经中风的神经保护机制
批准号:
8901174
负责人:
STEVEN L BERNSTEIN
金额:
$37.61万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2019-08-31

项目摘要

项目成果

STEVEN L BERNSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nonarteritic anterior ischemic optic neuropathy (NAION) is an optic nerve (ON) infarct, and the most common cause of sudden optic nerve (ON) related vision loss, NAION affects ~15,000 individuals/year and has no effective treatments. Little is known about the mechanisms in NAION pathophysiology. Our lab developed the first rodent and primate NAION models that have been validated for nearly every finding found in NAION, and us to critically dissect NAIONs likely processes. We have determined that early and late inflammatory changes play a key role in NAION model development and damage. Soon after NAION model induction, ON head edema and a compartment syndrome occur along with soluble inflammatory cytokine expression and progressive ischemia. Later (>3d) changes include significant cellular inflammatory infiltration, with increased M1 (degenerative macrophage response) and decreased M2 (regenerative macrophage response) activities, and progressive axon- and oligodendrocyte damage. These responses ultimately result in retinal ganglion cell (RGC) and oligodendrocyte death. We identified prostaglandin J2 (PGJ2) as the first agent that can potentially treat early stage disease. In aim 1, we will separately evaluate PGJ2's neuroprotective mechanisms, confirming their individual identities and their maximal effects. We will then determine whether these mechanisms act synergistically, to maximize neuroprotection. In aim 2, we will determine whether selectively immunomodulating the neuroprotective M2 macrophage inflammatory response will reduce RGC and myelin dysfunction and cellular death, and improve post-infarct recovery. Results of these interventions will be evaluated using a variety of techniques, to quantify effects at the gene expression level, histochemically and functionally. This combination early and later approaches is designed to maximize development of clinically effective treatments for NAION and related diseases, and greatly improve post- NAION recovery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of optic nerve lamina region stem cells in age-related optic nerve disease
  • 批准号:
    10443202
  • 项目类别:
  • 资助金额:
    $42.73万
  • 财政年份:
    2022
  • 负责人:
    STEVEN L BERNSTEIN
  • 依托单位:
The role of optic nerve lamina region stem cells in age-related optic nerve disease
  • 批准号:
    10707014
  • 项目类别:
  • 资助金额:
    $42.73万
  • 财政年份:
    2022
  • 负责人:
    STEVEN L BERNSTEIN
  • 依托单位:
Preclinical Analysis of Ischemic Optic Nerve Treatment
  • 批准号:
    9367979
  • 项目类别:
  • 资助金额:
    $34.95万
  • 财政年份:
    2017
  • 负责人:
    STEVEN L BERNSTEIN
  • 依托单位:
Preclinical analysis of ischemic optic nerve treatment
  • 批准号:
    8531941
  • 项目类别:
  • 资助金额:
    $23.23万
  • 财政年份:
    2009
  • 负责人:
    STEVEN L BERNSTEIN
  • 依托单位:
海外基金